Henry U. Bryant
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Bone Metabolism and Diseases, Menopause: Health Impacts and Treatments, Bone health and osteoporosis research, Bone health and treatments
Most-Cited Works
- → Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats(1996)287 cited
- → Molecular determinants of tissue selectivity in estrogen receptor modulators(1997)242 cited
- → Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo(2006)179 cited
- → Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene: A Novel, Highly Potent, Selective Estrogen Receptor Modulator(1997)176 cited
- → Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene(1997)175 cited
- → Immunosuppressive effects of chronic morphine treatment in mice(1987)134 cited